Skip to content

A Clinical Trial of Thread-embedding Therapy at Acupuncture Point for Simple Obesity

A Clinical Trial of Acupoint Thread-embedding Therapy for Simple Obesity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03325179
Enrollment
100
Registered
2017-10-30
Start date
2017-01-03
Completion date
2018-03-31
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple Obesity, Weight Loss

Keywords

Simple Obesity, Thread-embedding Therapy, Acupuncture

Brief summary

Thread-embedding Therapy has been used for treating Obesity in recent years. This research is aimed to observe the clinical effect of thread-embedding therapy in treating Simple Obesity. One hundred patients is planned to be enrolled in the research and receive a thread-embedding therapy. The level of BMI, serum triglyceride, cholesterol and fasting blood glucose will be adopted for evaluation before and after therapy.

Detailed description

Each participant will receive thread-embedding therapy every two weeks, and eight times in all.Blood test will be taken at the beginning of the first week of the whole therapy, and at the end of the 8th therapy. During the periods of whole therapy, the participants shall follow diets control and physical exercise as the protocol described.

Interventions

OTHERThread-embedding Therapy

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* patients with age from 18 to 60 years old; * patients with BMI≥ 24, meanwhile waist more than 85 cm (for male) or 80 cm (for female); * patients with diagnosed as central adiposity and/or Simple obesity according to the diagnosis criteria; * patients who is willing to cooperate with the test treatment and signed informed consent.

Exclusion criteria

* Pregnant or lactating women; * patients who Syncope after acupuncture; * patients who present hypersensitivity reactions after acupoint-embedding therapy; * patients with serious heart, liver, kidney, brain and other diseases; * patients with severe primary diseases; * patients with psychiatric diseases; * patients who did not meet the criteria for the inclusion criteria while investigators find out during the trial; * participants who did not complete dietary control and physical exercise as the protocol described.

Design outcomes

Primary

MeasureTime frameDescription
The change Body Weightparticipants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.a 5 percent of loss of body weight will be judged as effective

Secondary

MeasureTime frameDescription
The effection on cholesterolTherapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.a target examined by blood test, in order to compare the Lipid metabolism
The effection on triglycerideTherapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.a target examined by blood test, in order to compare the Lipid metabolism
The effection on fasting blood glucoseTherapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.to compare the level of glucose in order to get the message of improvement of blood glucose disorder by our therapy.

Countries

China

Contacts

Primary ContactMiao Wang
wangmiao_126@126.com+86-64385700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026